1. Home
  2. VRA vs GNLX Comparison

VRA vs GNLX Comparison

Compare VRA & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vera Bradley Inc.

VRA

Vera Bradley Inc.

HOLD

Current Price

$3.77

Market Cap

111.2M

ML Signal

HOLD

Logo Genelux Corporation

GNLX

Genelux Corporation

HOLD

Current Price

$2.86

Market Cap

133.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRA
GNLX
Founded
1982
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
111.2M
133.0M
IPO Year
2010
2022

Fundamental Metrics

Financial Performance
Metric
VRA
GNLX
Price
$3.77
$2.86
Analyst Decision
Hold
Strong Buy
Analyst Count
2
4
Target Price
N/A
$17.25
AVG Volume (30 Days)
227.6K
199.2K
Earning Date
06-10-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
20.47
9.47
EPS
N/A
N/A
Revenue
$416,097,000.00
$8,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2.50
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.39
$2.29
52 Week High
$4.39
$8.54

Technical Indicators

Market Signals
Indicator
VRA
GNLX
Relative Strength Index (RSI) 49.26 45.57
Support Level $3.02 $2.73
Resistance Level $3.80 $3.00
Average True Range (ATR) 0.19 0.15
MACD -0.02 -0.01
Stochastic Oscillator 4.78 15.79

Price Performance

Historical Comparison
VRA
GNLX

About VRA Vera Bradley Inc.

Vera Bradley Inc designs women's handbags, luggage, and travel items, fashion and home accessories, and gifts. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct and Vera Bradley Indirect.

About GNLX Genelux Corporation

Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.

Share on Social Networks: